Multiplikator Forward P/S: Novanta (NOVT)
Novanta Inc. is implementing sustainable standards in the development of photonic systems. Stable cash flows are supported by long-term demand for components, while high margins are based on the complexity of replacing OEM solutions. The forward P/S ratio visualizes the market valuation relative to expected revenue, with 1.30 serving as the current value of the parameter.
Ringkesan rincian data analitis Novanta Photonics (NOVT)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Novanta Inc.|NOVT - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Novanta Inc.|NOVT - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Novanta Photonics|NOVT - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Novanta|Rasio cepet novanta.com
- rincian asil keuangan lan kelipatan valuasi:
NOVT - Penghasilan resik perusahaan|Bathi sing dikarepake Novanta Inc.|NOVT - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Novanta Corp|NOVT - Pangali PEG|Pangali EV/EBITDA Novanta Photonics|NOVT - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Novanta|NOVT - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan novanta.com|NOVT - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Novanta Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:NOVT (Novanta)
Forward P/S evaluates market capitalization relative to expected revenue, allowing for the determination of the premium paid for future income streams. By analyzing the current forward P/S level on the GURU.Markets platform, an investor can see the monetization efficiency of Novanta Inc. high-precision lasers, where demand for critical robotic medicine components confirms the business's fundamental value even amidst market volatility.
Karo sapa Novanta Inc. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Haemonetics Corp. - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Inspire Medical Systems Inc|PRCT: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator Forward P/S|InMode Ltd (INMD) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S PMI|Multiplikator forward rega marang pendapatan Surmodics Inc. SRDX|Multiplikator Forward P/S SENS (Senseonics Holdings)|Multiplikator Forward P/S neuropace.com NPCE|TCMD - Rasio rega marang prakiraan pendapatan|SNWV: Rasio rega marang prakiraan pendapatan|OM (Outset) - Multiplikator forward rega marang pendapatan|Electromed - Rega forward marang dodolan|LNSR (LENSAR, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep avitamedical.com RCEL|Rasio rega marang prakiraan pendapatan Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Prakiraan rega marang pendapatan|EDAP TMS - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corporation)|Rasio rega marang prakiraan pendapatan Sensus Healthcare Corp|Multiplikator forward rega marang pendapatan Zynex Corp (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Inspira Technologies IINN|ICU: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|beyondair.net (XAIR) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan PFSA|Rasio rega marang prakiraan pendapatan STRATA Skin Sciences Inc.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep glucotrack.com GCTK|Multiplikator forward rega marang pendapatan NAOV (NanoVibronix)|Rasio rega marang prakiraan pendapatan VERO (Venus Concept Corporation)|Multiplikator Forward P/S NUWE (Nuwellis, Inc.)|Multiplikator Forward P/S aethlonmedical.com AEMD|ASXC - Rasio rega marang prakiraan pendapatan|AVGR (Avinger Inc.) - Kapitalisasi marang prakiraan pendapatan|BSGM (BioSig Technologies, Inc) - Multiplikator forward rega marang pendapatan|CUTR: Rasio rega marang pendapatan sing dikarepake|KNW (Know Labs, Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S inarimedical.com|Multiplikator forward rega marang pendapatan NVRO (Nevro)|RSLS (reshapelifesciences.com) - Rega forward marang dodolan|Multiplikator Forward P/S SILK (Silk Road Medical Inc.)
